Allogene Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Allogene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Allogene Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Allogene Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $13M | 4.1M | 3.21 |
| 2023-09-30 | $13M | 4.2M | 3.17 |
| 2023-06-30 | $24M | 4.8M | 4.97 |
| 2023-03-31 | $22M | 4.4M | 4.94 |
| 2022-12-31 | $3.6M | 571k | 6.29 |
| 2022-06-30 | $1.2M | 105k | 11.40 |
| 2022-03-31 | $24M | 2.7M | 9.11 |
| 2021-12-31 | $37M | 2.4M | 14.92 |
| 2021-09-30 | $8.9M | 348k | 25.70 |
| 2021-06-30 | $12M | 449k | 26.10 |
| 2021-03-31 | $3.0M | 85k | 35.32 |
| 2020-12-31 | $9.0M | 357k | 25.21 |
| 2020-09-30 | $3.4M | 91k | 37.23 |
| 2020-06-30 | $6.2M | 144k | 42.88 |
| 2020-03-31 | $1.8M | 94k | 19.34 |
| 2019-12-31 | $2.0M | 77k | 25.98 |
| 2019-09-30 | $9.8M | 361k | 27.26 |
| 2019-06-30 | $12M | 457k | 26.85 |
| 2019-03-31 | $20M | 684k | 28.91 |
| 2018-12-31 | $11M | 389k | 26.93 |